Prevalence of drug treatment of dyslipidemia in elderly persons with atherosclerotic vascular disease or diabetes mellitus

被引:0
|
作者
Ghosh, S [1 ]
Aronow, W [1 ]
机构
[1] New York Med Coll, New Rochelle, NY USA
来源
GERONTOLOGIST | 2002年 / 42卷
关键词
D O I
暂无
中图分类号
R4 [临床医学]; R592 [老年病学];
学科分类号
1002 ; 100203 ; 100602 ;
摘要
引用
收藏
页码:80 / 80
页数:1
相关论文
共 50 条
  • [1] Prevalence of combined atherosclerotic vascular lesions in patients with diabetes mellitus
    Gracheva, S. A.
    Klefortova, I. I.
    Shamkhalova, M. Sh.
    [J]. DIABETES MELLITUS, 2012, 15 (01): : 49 - 55
  • [2] Prevalence of dyslipidemia and risk factors in elderly patients with diabetes mellitus in China
    Liu, Yaoxia
    Chen, Ping
    Tian, Hui
    Zhang, Min
    Zhang, Min
    Cao, Xiaohong
    Chen, Jingyan
    Tang, Xialian
    Tang, Yiping
    Chen, Shu
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33
  • [3] Prevalence and treatment-status of dyslipidemia among persons with diabetes
    Kleisli, T
    Jacobs, MJ
    Wong, ND
    [J]. CIRCULATION, 2002, 106 (19) : 509 - 509
  • [4] Association of plasma homocysteine in elderly persons with atherosclerotic vascular disease and dementia, atherosclerotic vascular disease without dementia, dementia without atherosclerotic vascular disease, and no dementia or atherosclerotic vascular disease
    Storey, SG
    Suryadevara, V
    Aronow, WS
    Ahn, C
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2003, 58 (12): : 1135 - 1136
  • [5] Association of abnormal serum lipids in elderly persons with atherosclerotic vascular disease and dementia, atherosclerotic vascular disease without dementia, dementia without atherosclerotic vascular disease, and no dementia or atherosclerotic vascular disease
    Alm, C
    Storey, SG
    Aronow, WS
    Alm, C
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2003, 58 (09): : 859 - 861
  • [6] Diabetes Mellitus and Noncardiac Atherosclerotic Vascular Disease-Pathogenesis and Pharmacological Treatment Options
    Muzurovic, Emir M.
    Mikhailidis, Dimitri P.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2021, 26 (01) : 25 - 39
  • [7] DYSLIPIDEMIA IN DIABETES MELLITUS TYPE 2; PREVALENCE, PATHOPHYSIOLOGY, MANAGEMENT, AND TREATMENT
    Arfaj, Lama Khaled
    Fattani, Abdulelah Fareed
    Khamaj, Areen Jibreel
    Khamaj, Rawan Jabril
    Alnejaimi, Sultana Sedki H.
    Ismail, Hala Atif
    Al Tamimi, Mohammad Ghazi
    Elmoursi, Mohamed Maged Mohamed
    Saati, Amjad Mohammed
    Alyamani, Ghaday Ibrahim
    [J]. INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (12): : 17022 - 17028
  • [8] Dyslipidemia and prevention of atherosclerotic cardiovascular disease in the elderly
    Lucchi, Tiziano
    [J]. MINERVA MEDICA, 2021, 112 (06) : 804 - 816
  • [9] THE PREVALENCE OF DYSLIPIDEMIA IN YOUNG PATIENTS WITH DIABETES MELLITUS
    Ovsyannikova, Alla
    Rymar, Oksana
    Shaksthneider, Elena
    Ragino, Yulya
    Voevoda, Mikhail
    Shramko, Victorya
    [J]. ATHEROSCLEROSIS, 2017, 263 : E260 - E261
  • [10] Treatment of dyslipidemia in patients with diabetes mellitus
    Pikto-Pietkiewicz, W
    Wolkowska, K
    Pasierski, T
    [J]. PHARMACOLOGICAL REPORTS, 2005, 57 : 10 - 19